Skip to main content
. 2013 Jul 16;109(3):582–588. doi: 10.1038/bjc.2013.324

Figure 2.

Figure 2

Variation trends of breast density, endometrial thickness, estradiol (E2), and lipidemia. Note: Group (A), geserelin plus tamoxifen; group (B), tamoxifen alone. (A), E2; (B), breast density; (C), endometrial thickness; (D), triglycerides (TG); (E), Chol, cholesterol; (F), low-density lipoprotein (LDL); (G), high-density lipoprotein (HDL).